Navegando por Assunto COVID-19 - Treatment

Ir para: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
ou entre com as primeiras letras:  
Mostrando resultados 1 a 10 de 10
Data do documentoTítuloAutor(es)
Jan-2021Coronavirus disease (COVID-19) prevention and treatment methods and effective parameters: a systematic literature reviewRahmani, Amir Masoud; Mirmahaleh, Seyedeh Yasaman Hosseini
2020COVID-19 and the cardiovascular systemZheng, Ying-Ying; Ma, Yi-Tong; Zhang, Jin-Ying; Xie, Xiang
Set-2020COVID-19: transmission, prevention, and potential therapeutic opportunitiesLotfi, Melika; Hamblin, Michael R.; Rezaei, Nima
2021Current state of vaccine development and targeted therapies for COVID-19: impact of basic science discoveriesMarian, Ali J.
2020A human monoclonal antibody blocking SARS-CoV-2 infectionWang, Chunyan; Li, Wentao; Drabek, Dubravka; Okba, Nisreen M. A.; van Haperen, Rien; Osterhaus, Albert D. M. E.; van Kuppeveld, Frank J. M.; Haagmans, Bart L.; Grosveld, Frank; Bosch, Berend-Jan
Nov-2020Outcome of COVID-19 patients with use of Tocilizumab: a single center experienceZain Mushtaq, Muhammad; Bin Zafar Mahmood, Saad; Jamil, Bushra; Aziz, Adil; Ali, Syed Ahsan
Out-2020Point of view: should COVID-19 patients be supplemented with vitamin D?Annweiler, Cédric; Cao, Zhijian; Sabatier, Jean-Marc
Jan-2021Prevention and treatment of COVID-19: focus on interferons, chloroquine/hydroxychloroquine, azithromycin, and vaccineBakadia, Bianza Moise; He, Feng; Souho, Tiatou; Lamboni, Lallepak; Ullah, Muhammad Wajid; Boni, Biaou Ode; Ahmed, Abeer Ahmed Qaed; Mukole, Biampata Mutu; Yang, Guang
Jul-2020Towards treatment planning of COVID-19: rationale and hypothesis for the use of multiple immunosuppressive agents: anti-antibodies, immunoglobulins, and corticosteroidsSaghazadeh, Amene; Rezaei, Nima
Jul-2020Use of anakinra in severe COVID-19: a case reportFilocamo, Giovanni; Mangioni, Davide; Tagliabue, Paola; Aliberti, Stefano; Costantino, Giorgio; Minoia, Francesca; Bandera, Alessandra